两亲性树状接枝己内酯共聚物的合成与表征

通过树状接枝聚己内酯的侧羟基及端羟基与氯甲酰化的聚乙二醇进行接枝反应,得到带有亲水性聚乙二醇链段的新型两亲性树状接枝共聚物.1H-NMR分析显示,接枝率为50%左右.GPC分析结果表明,共聚物分子量呈较窄的单峰分布,分子量与接枝前相比明显增高.两亲性共聚物能直接分散在水中形成胶束溶液.以芘为荧光探针的测试结果表明其临界胶束浓度有降低.动态光散射测得胶束平均粒径在16至31 nm之间,粒径分散指数适中,PDI在0.25至0.39之间.TEM显示胶束粒子为不规整球形,由更小的粒径为几个纳米的微粒聚集而成,这些微粒的大小刚好与单个大分子的尺寸相匹配.因此,两亲性树状接枝聚己内酯在水相中存在单分子胶束与多分子组装胶束的平衡.得益于支化聚合物结构中的纳米空腔,两亲性树状接枝聚合物胶束对紫杉醇具有优良的包载能力.     

聚膦腈-g-聚己内酯共聚物的合成与表征

通过三甲基碘硅烷与聚二(2-甲氧基乙氧基)膦腈侧链上的醚键反应后水解得到侧链含部分羟基的聚膦腈,然后利用聚膦腈的侧链羟基在异辛酸亚锡催化作用下,引发己内酯单体开环聚合制备了聚膦腈-g-聚己内酯共聚物.该共聚物中聚己内酯链段的接枝率和侧链长度可通过改变三甲基碘硅烷和己内酯单体的投料来控制.     

聚膦腈-g-聚己内酯共聚物的合成与表征*

通过三甲基碘硅烷与聚二(2-甲氧基乙氧基)膦腈侧链上的醚键反应后水解得到侧链含部分羟基的聚膦腈,然后利用聚膦腈的侧链羟基在异辛酸亚锡催化作用下,引发己内酯单体开环聚合制备了聚膦腈-g-聚己内酯共聚物.该共聚物中聚己内酯链段的接枝率和侧链长度可通过改变三甲基碘硅烷和己内酯单体的投料来控制.     

聚己内酯大分子单体接枝丙烯酰胺共聚物的合成与表征

首次制备了末端为双键的功能化聚己内酯(PCL)大分子单体(AECL);AECL与丙烯酰胺(AM)在过硫酸钾引发剂作用下进行水溶液自由基聚合反应,合成了接枝PCL侧链的水溶性新型聚丙烯酰胺共聚物(PAM-g-PCL),其结构经1H NMR,IR和元素分析表征.PAM-g-PCL的特性粘数为3.4 dL·g-1～5.3 dL·g1-.     

两亲性嵌段共聚物mPEG-b-PCL/FA的合成及其药物释放性能

以苯甲醇为引发剂,在辛酸亚锡催化下引发ε-环己内酯(ε-CL )开环聚合,合成了聚己内酯(PCL).分别利用端甲氧基聚乙二醇(mPEG)、PCL及叶酸(FA)与三氯三嚎中不同的氯反应,得到两亲性嵌段共聚物mPEG-b-PCL/FA;采用傅立叶变换红外光谱仪和核磁共振谱仪等表征了mPEG-b-PCL/FA的组成和结构;采...     

乙基纤维素接枝聚己内酯药物缓释膜的制备及释药行为

在离子液体体系中通过开环聚合制备了用于药物缓释膜的乙基纤维素含量可控的乙基纤维素接枝聚己内酯共聚物(EC-g-PCL),并由1H-NMR谱图计算得到共聚物中[-CL]/[EC]葡萄糖单元的最大摩尔比为7 ∶1.AFM测试结果表明共聚物的表面随着PCL含量的增加而变得更加粗糙.EC-g-PCL共聚物中PCL链段可以结晶,且随着PCL含量的降低,结晶度逐步减小.偏光显微镜照片显示共聚物中PCL含量低于20%时,无法观测到清晰的PCL球晶结构,而高于这个含量的共聚物则可生成环带球晶.所有共聚物薄膜在PBS溶液中降解30天的失重量均大于纯PCL,且随着EC含量的增加失重量从2.51% 增加到8.31%.EC链的引入促进了PCL的降解.通过对负载药物双氯酚酸的共聚物薄膜的释药行为研究发现,其药物突释量和最大累计释放量均高于纯PCL的,释药动力学满足Ritger-Pappas方程:lnQ=0.3846lnt-1.8538,药物释放机制为Fickian扩散型,而PCL膜为non-Fickian扩散,即扩散与骨架溶蚀机制相结合.     

聚己内酯聚醚嵌段共聚物和共混物的表面性质对其药物释放行为的影响

聚己内酯聚醚嵌段共聚物和共混物的表面性质对其药物释放行为的影响王卫华,贝建中,王智峰,王身国（中国科学院化学研究所北京１０００８０）关键词聚己内酯聚醚嵌段共聚物,共混物,电子能谱,表面性质,药物释放行为聚己内醋（ＰＣＬ）具有优良的药物通透性和生物相容...     

乙酰化稻草/聚己内酯接枝共聚物的合成及表征

以稻草秸秆为原料,经粉碎后进行全植物秸秆的乙酰化改性,再用此乙酰化稻草同ε-己内酯(ε-CL)接枝共聚合成乙酰化稻草/聚己内酯接枝共聚物(ACSW-g-PCL)。研究了反应时间、反应温度、及单体用量对接枝率(G%)的影响。在反应温度140℃,反应时间10h,ε-CL对乙酰化稻草的质量比2:1时获得的接枝率最大为39%。产物的结构和性能通过红外光谱、核磁共振、扫描电镜、X-射线衍射和热分析仪表征,结果表明乙酰化稻草秸秆已成功接枝上聚己内酯(PCL)链段,经接枝ε-CL改性后的ACSW-g-PCL热稳定性有所改善,并具有了一定的热塑性。     

星型两亲性聚己内酯-b-聚甲基丙烯酸(2-羟乙酯)嵌段共聚物的合成和表征

通过开环聚合(ROP)和原子转移自由基聚合(ATRP)制备了一类新型的两亲性嵌段共聚物六臂星形聚(-己内酯)-b-聚甲基丙烯酸(2-羟乙酯)(6sPCL-b-PHEMA).6sPCL-b-PHEMA通过三步反应合成:(1)双季戊四醇开环聚合-己内酯的合成6sPCL;(2)以2-溴异丁基酰溴封端星形聚合物制备大分子引发剂6sPCL-Br;(3)采用溴化亚铜 [Cu(I)Br]和2,2'-联吡啶(Bpy) 催化甲基丙烯酸(2-羟乙酯) (HEMA)单体聚合合成具有不同亲疏水链段比的6sPCL-b-PHEMA.通过核磁氢谱(1H-NMR)和红外光谱(FT-IR)对共聚物的化学结构进行表征,确认合成了目标产物.利用示差扫描量热仪(DSC) 对其热性能并利用接触角测量仪对材料的膜的亲水性进行了研究,结果表明,PCL与HEMA进行共聚以后,可以降低PCL的结晶性并提高聚合物的亲水性,随着HEMA在共聚物中含量的增加,这种趋势更加明显.     

两亲性嵌段共聚物PCL-b-PNVP的合成及其自组装行为的研究

以4-羟基-2,2,4,4-四甲基哌啶氮氧自由基为引发剂,通过ε-己内酯（ε-CL）的开环聚合反应,合成氮氧稳定自由基为末端基的聚己内酯（PCL-T）;在其＂介调＂下,进行乙烯基吡咯烷酮（NVP）的氮氧稳定自由基聚合（NMP）,得到结构规整聚己内酯和聚乙烯吡咯烷酮两亲性的嵌段共聚物（PCL-b-PNVP）.通过核磁共振...     

Synthesis, characterization and self-assemble behavior of chitosan-O-poly(ε-caprolactone)

A facile strategy was proposed for synthesizing chitosan-O-poly(ε-caprolactone) (CS-O-PCL). Stoichiometric sodium dodecyl sulfate-chitosan complex (SCC) which was soluble in common organic solvents was adopted as an intermediate. Regioselective conjugation of PCL onto SCC could be achieved through condensation reaction between isocyanate-terminated PCL and hydroxyl groups of chitosan. The grafting level of PCL could be modulated by varying PCL/SCC weight ratio. SDS was removed from SCC-O-PCL using trihydroxymethylamine (Tris) as a decomplexation agent. The self-assemble behavior of the amphiphilic copolymers was studied by fluorometry, TEM and laser light scattering. The morphology of the CS-O-PCL nanoparticles was found to be dependent on PCL grafting level. Both spherical micelles and vesicle could be formed by dialysis method.     

不同内核结构PEG-b-PCL胶束的制备及其载药性能的研究

以聚乙二醇单甲醚作大分子引发剂,异辛酸亚锡作催化剂,将不同比例的-己内酯(CL)与4-甲基--己内酯(MCL)单体开环共聚,并通过控制CL和MCL的投料比以及投料方式,得到了疏水链段上CL和MCL不同比例和分布的4组聚合物.核磁和凝胶渗透色谱法表征了聚合物的结构,示差扫描量热法,广角X射线衍射和红外光谱表征了聚合物的结晶性.采用透析的方法,制备了4种聚合物的纳米胶束,以及载药(阿霉素DOX)胶束,并研究了胶束的自组装行为以及对阿霉素的包裹和释放情况.结果表明MCL单体的引入降低了聚合物的结晶性,提高了对DOX的载药量,加快了DOX的释放.通过激光共聚焦显微镜和流式细胞仪研究了 HepG2 肝癌细胞对不同内核结构载药胶束的内吞情况,并用 MTT 法考察了胶束对细胞的毒害作用,细胞实验发现,HepG2细胞对载DOX胶束的内吞以及载DOX胶束对细胞的杀伤能力和胶束内核的结构相关.     

Supercritical carbon dioxide assisted synthesis of amphiphilic graft copolymers based on poly(styrene-co-maleic anhydride) with methoxyl poly(ethylene glycol) side chains

Supercritical carbon dioxide (scCO2) was used as a reaction medium in synthesizing amphiphilic graft copolymers composed of poly(styrene-co-maleic anhydride) (SMA) backbones and methoxyl poly(ethylene glycol) (MPEG) side chains via esterification.The synthesized copolymers were characterized by Four     

孕二烯酮生物可降解缓释植入剂的制备及体外药物释放

以聚己内酯(PCL)为载体材料,采用双螺杆挤出工艺制备了孕二烯酮缓释植入剂。采用凝胶渗透色谱仪(GPC)测定分子量,扫描电镜(SEM)观察结构,红外光谱分析(FT-IR)分析药物载体状态,紫外分光光度法(UV)测定植入剂的载药量和药物释放情况。结果表明:挤出后载体分子量无明显变化;挤出工艺对载药植入剂成形性好,表面无药物析出;药物与载体以物理混合方式存在;该植入剂在体外可长效释药,趋于一级药物释放模式(r2=0.9948)。     

聚对二氧环己酮/聚乙二醇多嵌段共聚物的合成与表征

首先合成双端羟基的聚对二氧环己酮预聚物(PPDO)和双端羧基的聚乙二醇预聚物（PEG）,然后以丁二酸酐/二环己基碳二亚胺（DCC）将PPDO与PEG偶联共聚,得到PPDO/PEG多嵌段共聚物.通过1H-NMR和GPC表征了聚合物的结构和分子量.采用差示扫描量热法（DSC）和热重分析（TGA）研究了共聚物的结晶性能和热稳定性.用透析法制备了共聚物纳米粒子,并用动态光散射（DLS）表征了共聚物纳米粒子的粒径及分散度,结果表明,随着共聚物亲水链段PEG含量的增加,其纳米粒子更易形成,粒子粒径随共聚物分子量增大而增大.     

侧链末端含荧光基团芘的EC-g-PCL梳形共聚物的合成与性能研究

首先以乙基纤维素(EC)为大分子引发剂引发-己内酯(CL)的开环聚合反应(ROP),合成乙基纤维素接枝聚-己内酯的梳形共聚物(EC-g-PCL).之后利用N,N'-二环己基碳二亚胺(DCC)做脱水剂将荧光基团芘(Pyr)引入侧链聚-己内酯(PCL)末端,经控制投料比,合成不同含量芘端基的乙基纤维素接枝聚-己内酯的荧光梳形共聚物(EC-g-PCL-Pyr).利用傅里叶变换红外(FTIR)、核磁共振(NMR)对其结构进行表征,运用差示扫描量热仪(DSC)和原子力显微镜(AFM)研究其热性能和结晶性能,通过紫外-可见光谱(UV-Vis)、荧光光谱对其光学性质进行研究.研究结果表明该荧光梳形共聚物的荧光强度与芘的接枝量有关.     

AN APPROACH TO SYNTHESIZE POLY(ETHYLENE GLYCOL)-b-POLY(ε-CAPROLACTONE) WITH TERMINAL AMINO GROUP via SCHIFF’S BASE AS AN INITIATOR

A new method to synthesize a degradable terminal amino group-containing copolymer, poly(ethylene glycol)-b-poly(ε-caprolactone) (MPEG-PCL-NH2), was developed in the following three steps: (1) the ring-opening polymerization (ROP) of ε-caprolactone from the Schiff base prepared from benzaldehyde and ethanolamine (Ph―CH＝NCH2CH2OH) used as an initiator to obtain heterobifunctional poly(ε-caprolactone) with one terminal Schiff base group and one hydroxyl group (HO-PCL-CH2CH2N＝CH―Ph); (2) the coupling reaction of two reactive precursors, a hydroxy-terminated HO-PCL-CH2CH2N＝CH―Ph and α-monocarboxy-ω-monomethoxy poly(ethylene glycol) (CMPEG) to synthesize MPEG-PCL-CH2CH2N＝CH―Ph; (3) the conversion of the ―N＝CH―Ph end-group into NH2 end-group by acidification of acetic acid to obtain MPEG-PCL-NH2. The structures from the precursors to the terminal amino group-containing copolymer were confirmed by 1H-NMR and their molecular weights were measured by gel permeation chromatography. The amphiphilic terminal amino group-containing copolymer could self-assemble into micelles in an aqueous system with PCL block as the core and PEG block as the shell. The micelle formation of the terminal amino group-containing block copolymer was studied by fluorescent probe technique and the existence of critical micellar concentration (cmc) confirmed the amphiphilic nature of the resulting copolymer. ESEM and DLS analysis of the micelles revealed a homogeneous spherical morphology and a unimodal size distribution.     

Effect of poly(ethylene oxide) on the release behaviors of poly(epsilon-caprolactone) microcapsules containing erythromycin

The biodegradable poly(epsilon-caprolactone) (PCL)/poly(ethylene oxide) (PEO) microcapsules and the analyzing of form and features for the manufacturing conditions were investigated in a prospective drug delivery systems (DDS) through drug release. The effects of emulsifier, emulsifier concentration, and stirring rate on the diameter and form of the microcapsules were examined using image analyzer (IA) and scanning electron microscope (SEM). The role of interfacial adhesion between PCL/PEO and drug was determined by contact angle measurements, and the drug release rate of the microcapsules was characterized by UV-vis spectroscopy. As a result, the microcapsules were made in spherical forms with a mean particle size of 170 nm approximately 68 microm. And the work of adhesion between water and PCL/PEO was increased with increasing the PEO content, which is due to higher hydrophilicity of PEO. The drug release rate of the microcapsules was significantly increased as the PEO content increased, which could be attributed to the increasing of the hydrophilic groups or the degree of adhesion at the interfaces.     

Crystallization Behavior and Dynamic Mechanical Properties of Poly(ε-caprolactone)/Octaisobutyl-Polyhedral Oligomeric Silsesquioxanes Composites Prepared via Different Methods

Two octaisobutyl-polyhedral oligomeric silsesquioxanes(oib-POSS)reinforced biodegradable poly(ε-caprolactone)(PCL)composites were prepared via two different methods,i.e.,melt compounding and solution casting,which were named as m PCL/oib-POSS and s PCL/oibPOSS,respectively,in this work.Oib-POSS dispersed finely in both composites;moreover,oib-POSS aggregates were larger in m PCL/oib-POSS than in s PCL/oib-POSS.Despite the different preparation methods,oib-POSS obviously promoted the crystallization of PCL,especially in s PCL/oib-POSS,but did not modify the crystal structure of PCL.The storage moduli of PCL were improved significantly in both composites.PCL/oib-POSS composites with enhanced crystallization behavior and improved dynamic mechanical properties were successfully prepared through both methods;moreover,the solution casting method was more effective than the melt compounding method.